Download PDF
Am J Perinatol 2024; 41(01): 053-059
DOI: 10.1055/s-0041-1740213
Original Article

Urinary N-terminal Pro-Brain Natriuretic Peptide in Newborn Infants with Cardiac and Pulmonary Diseases

Marwa M. Elgendy 
1   Department of Neonatology, Cleveland Clinic Children's, Cleveland, Ohio
,
Rania Salah Elzayat
2   Department of Pediatrics, Menoufia University Hospitals, Menoufia, Egypt
,
Mostafa Abdo
2   Department of Pediatrics, Menoufia University Hospitals, Menoufia, Egypt
,
Hamed M. Elsharkawy
3   Department of Pediatrics, Tanta University Hospitals, Tanta, Egypt
,
Maha Allam
4   Department of Clinical Pathology, National Liver Institute, Menoufia, Egypt
,
Dina Abdelrazek Midan
2   Department of Pediatrics, Menoufia University Hospitals, Menoufia, Egypt
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Objectives The aim of this study was to assess the feasibility of urinary N-terminal pro-brain natriuretic peptide (NT-proBNP) as noninvasive screening tool for congenital heart diseases in full-term neonates with respiratory distress.

Study Design A prospective cohort study was conducted on 90 full-term infants. Newborn were assigned into three groups: pulmonary, cardiac, and control groups. Urinary NT-proBNP were measured in all studied groups at day 1 (NT-proBNP1) and day 5 (NT-proBNP5).

Results Urinary NT-proBNP1 was higher in cardiac group compared with pulmonary and control groups (488 ± 91, 321 ± 80, and 218 ± 41 ng/L, respectively; p ≤ 0.001). NT-proBNP5 was lower in pulmonary and control group than cardiac group (245 ± 84, 137 ± 39, and 546 ± 284 ng/L, respectively, with p ≤ 0.001). Receiver operating characteristic (ROC) analysis was performed to assess predictive value of NT-proBNP1 in cardiac and pulmonary populations. ROC showed area under curve of 0.97 and cutoff point of ≥386.5 ng/L referring to a cardiac etiology with sensitivity of 93.3%, specificity of 86.7%, negative predictive value of 93%, and positive predictive value of 88%.

Conclusion Urinary NT-proBNP is feasible to be a noninvasive screening tool to predict congenital heart diseases in full-term neonates. Further studies are needed to assess the correlation between plasma and urinary levels of NT-proBNP in congenital heart diseases in full-term and preterm infants.

Keywords

respiratory distress - neonates - cardiac - urinary - plasma - BNP

Authors Contributions

M.M.E., M.A., H.M.E., and D.A.M. conceptualized and designed the study, interpreted the statistical analyses, drafted the initial manuscript, reviewed and revised the manuscript, coordinated and supervised data collection, and critically reviewed the manuscript for important intellectual content. M.A. and R.S.E. conceptualized and designed the study, performed the initial analyses, and critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.


Ethical Approval

The study was approved by the local Ethics Committee of Faculty of Medicine, Menoufia University, and it complies with the Helsinki Declaration of 1964, as revised in 2013.


Patient Consent

Written informed consent was obtained from the parents of all subjects of the study before enrollment.




Publication History

Received: 07 April 2021

Accepted: 14 October 2021

Article published online:
02 December 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Warren JB, Anderson JM. Newborn respiratory disorders. Pediatr Rev 2010; 31 (12) 487-495 , quiz 496
    CrossrefPubMedGoogle Scholar
  • 2 Edwards MO, Kotecha SJ, Kotecha S. Respiratory distress of the term newborn infant. Paediatr Respir Rev 2013; 14 (01) 29-36 , quiz 36–37
    CrossrefPubMedGoogle Scholar
  • 3 Sivakumaran D, Nirosha P. A study of respiratory distress in term neonates in early neonatal period. Int J Sci Stud 2017; 5 (06) 94-97
    PubMedGoogle Scholar
  • 4 Hermansen CL, Lorah KN. Respiratory distress in the newborn. Am Fam Physician 2007; 76 (07) 987-994
    PubMedGoogle Scholar
  • 5 Vijlbrief DC, Benders MJNL, Kemperman H, van Bel F, de Vries WB. Use of cardiac biomarkers in neonatology. Pediatr Res 2012; 72 (04) 337-343
    CrossrefPubMedGoogle Scholar
  • 6 Nishikimi T, Kuwahara K, Nakao K. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol 2011; 57 (02) 131-140
    CrossrefPubMedGoogle Scholar
  • 7 Elin RJ, Winter WE. Laboratory and clinical aspects of B-type natriuretic peptides. Arch Pathol Lab Med 2004; 128 (06) 697-699
    CrossrefPubMedGoogle Scholar
  • 8 Hammerer-Lercher A, Mair J, Tews G, Puschendorf B, Sommer R. N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers. Clin Chem 2005; 51 (05) 913-915
    CrossrefPubMedGoogle Scholar
  • 9 Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 2006; 366 (1–2): 304-308
    CrossrefPubMedGoogle Scholar
  • 10 El-Khuffash AF, Amoruso M, Culliton M, Molloy EJ. N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study. Arch Dis Child Fetal Neonatal Ed 2007; 92 (05) 421-422
    CrossrefPubMedGoogle Scholar
  • 11 Markovic-Sovtic G, Kosutic J, Jankovic B. et al. N-terminal pro-brain natriuretic peptide in the assessment of respiratory distress in term neonates. Pediatr Int 2014; 56 (03) 373-377
    CrossrefPubMedGoogle Scholar
  • 12 Joseph L, Nir A, Hammerman C, Goldberg S, Ben Shalom E, Picard E. N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants. Am J Perinatol 2010; 27 (05) 381-386
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Snoek KG, Kraemer US, Ten Kate CA. et al. High-sensitivity troponin T and N-terminal pro-brain natriuretic peptide in prediction of outcome in congenital diaphragmatic hernia: results from a multicenter, randomized controlled trial. J Pediatr 2016; 173: 245-249.e4
    CrossrefPubMedGoogle Scholar
  • 14 Noori NM, Savadkoohi S, Teimouri A, Alizadeh F. Evaluation of serum levels of N-terminal pro brain natriuretic peptide and atrial natriuretic peptide in neonates with respiratory distress. Int J Pediatr 2016; 4 (06) 1847-1856
    PubMedGoogle Scholar
  • 15 Lang RM, Badano LP, Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28 (01) 1-39.e14
    CrossrefPubMedGoogle Scholar
  • 16 Rudski LG, Lai WW, Afilalo J. et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23 (07) 685-713 , quiz 786–788
    CrossrefPubMedGoogle Scholar
  • 17 Shashidhar A, Suman Rao PN, Joe J. Downes score vs Silverman Anderson score for assessment of respiratory distress in preterm newborns. Pediatr Oncall 2016; 13 (03) 66-68
    PubMedGoogle Scholar
  • 18 Wood DW, Downes JJ, Lecks HI. A clinical scoring system for the diagnosis of respiratory failure. Preliminary report on childhood status asthmaticus. Am J Dis Child 1972; 123 (03) 227-228
    CrossrefPubMedGoogle Scholar
  • 19 Ahmed AM, Mohamed NAE, Abdelhamid EM, Taha RI, Abo-Hashish MMA. N-terminal pro-brain natriuretic peptide as a biomarker for differentiating cardiac and pulmonary disease in term neonates with respiratory distress. J Saudi Heart Assoc 2020; 32 (01) 65-70
    PubMedGoogle Scholar
  • 20 Ko HK, Lee JH, Choi BM. et al. Utility of the rapid B-type natriuretic peptide assay for detection of cardiovascular problems in newborn infants with respiratory difficulties. Neonatology 2008; 94 (01) 16-21
    CrossrefPubMedGoogle Scholar
  • 21 Schwachtgen L, Herrmann M, Georg T, Schwarz P, Marx N, Lindinger A. Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children. Z Kardiol 2005; 94 (06) 399-404
    CrossrefPubMedGoogle Scholar
  • 22 Yoshibayashi M, Kamiya T, Saito Y. et al. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 1995; 133 (02) 207-209
    CrossrefPubMedGoogle Scholar
  • 23 Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 2003; 89 (08) 875-878
    CrossrefPubMedGoogle Scholar
  • 24 Cantinotti M, Passino C, Storti S, Ripoli A, Zyw L, Clerico A. Clinical relevance of time course of BNP levels in neonates with congenital heart diseases. Clin Chim Acta 2011; 412 (23–24): 2300-2304
    CrossrefPubMedGoogle Scholar
  • 25 Biondi JW, Schulman DS, Soufer R. et al. The effect of incremental positive end-expiratory pressure on right ventricular hemodynamics and ejection fraction. Anesth Analg 1988; 67 (02) 144-151
    CrossrefPubMedGoogle Scholar
  • 26 Naeem B, Ayub A, Aly AM, Malloy MH, Okorodudu AO, Jain SK. Urinary NT-proBNP as a potential noninvasive biomarker for screening of pulmonary hypertension in preterm infants: a pilot study. J Perinatol 2020; 40 (04) 628-632
    CrossrefPubMedGoogle Scholar